{"entity":{"type":"insider","cik":"0001456586","url":"/insider/0001456586","json_url":"/insider/0001456586.json","name":"Versant Venture Capital III, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":8,"first":"2010-08-10","last":"2016-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Versant Venture Capital III, L.P.","source":"filing","n_filings":8,"first_seen":"2010-08-10","last_seen":"2016-06-10"}],"transactions":[{"id":2650541,"accession":"0001104659-16-126659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-126659","line_url":"/filing/0001104659-16-126659#line-2","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ATWOOD BRIAN G; ROBERTSON REBECCA B; COLELLA SAMUEL D; Versant Venture Capital III, L.P.; LINK WILLIAM J PHD; Versant Ventures III, LLC; JAFFE ROSS A MD; Versant Side Fund III, L.P.; MILDER DONALD B; Versant Development Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":710091.0,"shares_display":"710,091","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":9941274.0,"total_display":"9,941,274.00","shares_owned_after":3511670.0,"shares_owned_after_display":"3,511,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-08","filed_date":"2016-06-10","scope":"insider"},{"id":2650537,"accession":"0001104659-16-126659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-126659","line_url":"/filing/0001104659-16-126659#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ATWOOD BRIAN G; ROBERTSON REBECCA B; COLELLA SAMUEL D; Versant Venture Capital III, L.P.; LINK WILLIAM J PHD; Versant Ventures III, LLC; JAFFE ROSS A MD; Versant Side Fund III, L.P.; MILDER DONALD B; Versant Development Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4194.0,"shares_display":"4,194","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":58716.0,"total_display":"58,716.00","shares_owned_after":20739.0,"shares_owned_after_display":"20,739","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-08","filed_date":"2016-06-10","scope":"insider"},{"id":3184598,"accession":"0001144204-16-104556","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556#line-6","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182914.0,"shares_display":"182,914","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":1829.14,"total_display":"1,829.14","shares_owned_after":1334617.0,"shares_owned_after_display":"1,334,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":3184595,"accession":"0001144204-16-104556","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556#line-5","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73615.0,"shares_display":"73,615","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":736.15,"total_display":"736.15","shares_owned_after":1517531.0,"shares_owned_after_display":"1,517,531","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":3184589,"accession":"0001144204-16-104556","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556#line-4","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1080.0,"shares_display":"1,080","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":10.8,"total_display":"10.80","shares_owned_after":7885.0,"shares_owned_after_display":"7,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":3184587,"accession":"0001144204-16-104556","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556#line-3","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":435.0,"shares_display":"435","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":4.35,"total_display":"4.35","shares_owned_after":8965.0,"shares_owned_after_display":"8,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":3184584,"accession":"0001144204-16-104556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556#line-2","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":596477.0,"shares_display":"596,477","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":2982385.0,"total_display":"2,982,385.00","shares_owned_after":1931094.0,"shares_owned_after_display":"1,931,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":3184580,"accession":"0001144204-16-104556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-104556","line_url":"/filing/0001144204-16-104556#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.; LUBASH BARBARA N; Versant Ventures III, LLC; MILDER DONALD B; Praeger Robin L.; COLELLA SAMUEL D; JAFFE ROSS A MD; LINK WILLIAM J PHD; ATWOOD BRIAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3523.0,"shares_display":"3,523","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":17615.0,"total_display":"17,615.00","shares_owned_after":11408.0,"shares_owned_after_display":"11,408","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":8344701,"accession":"0001209191-15-053412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-053412","line_url":"/filing/0001209191-15-053412#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":null,"owner_name":"Versant Side Fund III, L.P.; Versant Venture Capital III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":318122.0,"shares_display":"318,122","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":6998684.0,"total_display":"6,998,684.00","shares_owned_after":2202377.0,"shares_owned_after_display":"2,202,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-15","scope":"insider"},{"id":8344697,"accession":"0001209191-15-053412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-053412","line_url":"/filing/0001209191-15-053412#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":null,"owner_name":"Versant Side Fund III, L.P.; Versant Venture Capital III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1878.0,"shares_display":"1,878","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":41316.0,"total_display":"41,316.00","shares_owned_after":13007.0,"shares_owned_after_display":"13,007","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-15","scope":"insider"},{"id":8793446,"accession":"0001209191-15-052367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-052367","line_url":"/filing/0001209191-15-052367#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":424494.0,"shares_display":"424,494","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":9338868.0,"total_display":"9,338,868.00","shares_owned_after":2520499.0,"shares_owned_after_display":"2,520,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-10","filed_date":"2015-06-11","scope":"insider"},{"id":8793445,"accession":"0001209191-15-052367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-052367","line_url":"/filing/0001209191-15-052367#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2506.0,"shares_display":"2,506","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":55132.0,"total_display":"55,132.00","shares_owned_after":14885.0,"shares_owned_after_display":"14,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-10","filed_date":"2015-06-11","scope":"insider"},{"id":8498984,"accession":"0001140361-15-019195","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001140361-15-019195","line_url":"/filing/0001140361-15-019195#line-8","is_derivative":false,"issuer_cik":"0001293818","issuer_name":"OPGEN INC","issuer_ticker":"OPGNOPGNW","issuer_name_source":null,"issuer_url":"/issuer/0001293818","owner_cik":null,"owner_name":"Versant Side Fund III, L.P.; Versant Ventures III, LLC; Versant Venture Capital III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":410906.0,"shares_display":"410,906","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2465436.0,"total_display":"2,465,436.00","shares_owned_after":483072.0,"shares_owned_after_display":"483,072","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-08","filed_date":"2015-05-12","scope":"insider"},{"id":8498980,"accession":"0001140361-15-019195","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001140361-15-019195","line_url":"/filing/0001140361-15-019195#line-7","is_derivative":false,"issuer_cik":"0001293818","issuer_name":"OPGEN INC","issuer_ticker":"OPGNOPGNW","issuer_name_source":null,"issuer_url":"/issuer/0001293818","owner_cik":null,"owner_name":"Versant Side Fund III, L.P.; Versant Ventures III, LLC; Versant Venture Capital III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2426.0,"shares_display":"2,426","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":14556.0,"total_display":"14,556.00","shares_owned_after":2853.0,"shares_owned_after_display":"2,853","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-08","filed_date":"2015-05-12","scope":"insider"},{"id":6571676,"accession":"0001123292-14-000785","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001123292-14-000785","line_url":"/filing/0001123292-14-000785#line-6","is_derivative":false,"issuer_cik":"0001437786","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001437786","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208334.0,"shares_display":"208,334","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2500008.0,"total_display":"2,500,008.00","shares_owned_after":1974877.0,"shares_owned_after_display":"1,974,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2014-07-31","scope":"insider"},{"id":6571672,"accession":"0001123292-14-000785","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001123292-14-000785","line_url":"/filing/0001123292-14-000785#line-5","is_derivative":false,"issuer_cik":"0001437786","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001437786","owner_cik":null,"owner_name":"Versant Venture Capital III, L.P.; Versant Side Fund III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":233333.0,"shares_display":"233,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2799996.0,"total_display":"2,799,996.00","shares_owned_after":2208210.0,"shares_owned_after_display":"2,208,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2014-07-31","scope":"insider"},{"id":6375356,"accession":"0001209191-14-012247","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-012247","line_url":"/filing/0001209191-14-012247#line-7","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":null,"owner_name":"Versant Side Fund III, L.P.; Versant Development Fund III, L.P.; Versant Venture Capital III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":305886.0,"shares_display":"305,886","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":3976518.0,"total_display":"3,976,518.00","shares_owned_after":3205001.0,"shares_owned_after_display":"3,205,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":6375352,"accession":"0001209191-14-012247","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-012247","line_url":"/filing/0001209191-14-012247#line-6","is_derivative":false,"issuer_cik":"0001419600","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001419600","owner_cik":null,"owner_name":"Versant Side Fund III, L.P.; Versant Development Fund III, L.P.; Versant Venture Capital III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1806.0,"shares_display":"1,806","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":23478.0,"total_display":"23,478.00","shares_owned_after":3206807.0,"shares_owned_after_display":"3,206,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":7490101,"accession":"0001181431-10-041137","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-041137","line_url":"/filing/0001181431-10-041137#line-3","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":null,"owner_name":"Versant Side Fund III, L.P.; Versant Venture Capital III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":914529.0,"shares_display":"914,529","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":4572645.0,"total_display":"4,572,645.00","shares_owned_after":3235839.0,"shares_owned_after_display":"3,235,839","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-06","filed_date":"2010-08-10","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Ten percent owner","n_filings":2,"first_seen":"2014-02-20","last_seen":"2016-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001429386","name":"PHASERX, INC.","url":"/issuer/0001429386","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-24","last_seen":"2016-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Ten percent owner","n_filings":2,"first_seen":"2015-06-11","last_seen":"2015-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001293818","name":"OPGEN INC","url":"/issuer/0001293818","role":"Ten percent owner","n_filings":1,"first_seen":"2015-05-12","last_seen":"2015-05-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001437786","name":"Immune Design Corp.","url":"/issuer/0001437786","role":"Ten percent owner","n_filings":1,"first_seen":"2014-07-31","last_seen":"2014-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Ten percent owner","n_filings":1,"first_seen":"2010-08-10","last_seen":"2010-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001456586","retrieved_at":"2026-08-22T04:42:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}